PIQL.F logo

Proteomics International Laboratories OTCPK:PIQL.F Stock Report

Last Price

US$0.31

Market Cap

US$40.2m

7D

0%

1Y

n/a

Updated

15 Mar, 2025

Data

Company Financials

Proteomics International Laboratories Ltd

OTCPK:PIQL.F Stock Report

Market Cap: US$40.2m

PIQL.F Stock Overview

Operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and South East Asia. More details

PIQL.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Proteomics International Laboratories Ltd Competitors

Price History & Performance

Summary of share price highs, lows and changes for Proteomics International Laboratories
Historical stock prices
Current Share PriceAU$0.31
52 Week HighAU$0.31
52 Week LowAU$0.31
Beta0.35
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO0%

Recent News & Updates

Recent updates

Shareholder Returns

PIQL.FUS Life SciencesUS Market
7D0%-2.2%-2.2%
1Yn/a-19.2%9.5%

Return vs Industry: Insufficient data to determine how PIQL.F performed against the US Life Sciences industry.

Return vs Market: Insufficient data to determine how PIQL.F performed against the US Market.

Price Volatility

Is PIQL.F's price volatile compared to industry and market?
PIQL.F volatility
PIQL.F Average Weekly Movementn/a
Life Sciences Industry Average Movement9.6%
Market Average Movement6.4%
10% most volatile stocks in US Market17.4%
10% least volatile stocks in US Market3.4%

Stable Share Price: PIQL.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine PIQL.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001n/aRichard Lipscombewww.proteomics.com.au

Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and South East Asia. It provides PromarkerD, a protein-based diagnostic blood test to predict diabetic kidney disease (DKD). The company’s products under development include PromarkerEndo, which has completed clinical validation phase for endometriosis diagnosis; PromarkerEso, that has completed clinical validation trials for esophageal cancer diagnosis; and OxiDx (2-tag), which has completed clinical validation phase for oxidative stress treatment.

Proteomics International Laboratories Ltd Fundamentals Summary

How do Proteomics International Laboratories's earnings and revenue compare to its market cap?
PIQL.F fundamental statistics
Market capUS$40.20m
Earnings (TTM)-US$4.50m
Revenue (TTM)US$2.21m

18.2x

P/S Ratio

-8.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PIQL.F income statement (TTM)
RevenueAU$3.50m
Cost of RevenueAU$2.04m
Gross ProfitAU$1.46m
Other ExpensesAU$8.57m
Earnings-AU$7.11m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.054
Gross Margin41.64%
Net Profit Margin-203.39%
Debt/Equity Ratio0%

How did PIQL.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/15 06:43
End of Day Share Price 2025/01/16 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Proteomics International Laboratories Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Iain WilkieMorgans Financial Limited